Solgate Gmbh Is An Austrian Biotechnology Company Established In 2020Focusing On Drug Discovery That Targets Solute Carrier Proteinsslcs These Proteins Play A Significant Role In Various Disordersincluding Neurologicalautoimmuneand Metabolic Conditionsheadquartered At Ist Park Near Ist Austriasolgate Combines Expertise In Chemistrycell Biologyand Advanced Analytics To Develop Therapies That Influence Cellular Metabolism The Company Operates A Proprietary Drug Discovery Platform That Utilizes Cell Based Assaysmedicinal Chemistryand Structural Biology To Identify And Optimize Compounds Targeting Slcssolgate Emphasizes The Physiological Relevance Of Its Assayswhich Are Conducted Under Native Cellular Conditions To Enhance Hit Identificationtheir Pipeline Includes Drug Candidates Aimed At Restoring Metabolic Balance In Specific Tissueswith A Focus On Advancing These Candidates Into Precision Therapiessolgate Is Committed To Bridging The Gap Between Target Validation And Clinical Development Through Its Innovative Research Approach
United States
